You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Cannula System for "Bridge to Recovery" Cardiac Assist

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cardiac failure is the, largest single cause of mortality in the United States today. With an increase in the use of long-term cardiac assist devices, there is also a need for the short-term "bridge to recovery" application. This application is intended to provide a low-cost temporary support for patients whose heart is capable of recovering. This "patient scr ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Digoxin Chiral Isolates as Improved Pharmaceuticals

    SBC: ACADEMIC PHARMACEUTICALS            Topic: N/A

    DESCRIPTION (provided by applicant): Digoxin is the first line pharmacologic therapy for CHF and AF. Digoxin increases cardiac contractility and blocks conduction through the AV node slowing the ventricular response to AF and thus slowing the rate of the beating ventricles permitting more time for the heart to fill. The recent Dig trial supports the use of digoxin in the treatment of CHF and the r ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. A2a Adenosine Agonist Cardiac Reperfusion Injury

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Founded in 1999, Adenosine Therapeutics LLC (ATL) is a drug discovery and development company that has developed a family of potent and selective adenosine A2A receptor agonists. With the help of STTR funding, ATL has developed a lead adenosine A2A receptor agonist, ATL-146e, that is currently in late Phase II of clinical development for use as a coronary vaso ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Vascular Permeability Normalization in Ischemic Stroke

    SBC: Advanced Life Sciences, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Stroke is the third leading cause of death in the United States and is the number one cause of adult disability. It is estimated that this clinical condition results in a cost of $30-40 billion in the U.S alone. While a large number of therapeutic agents have been investigated for the treatment of ischemic stroke, only one agent is currently approved for marke ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Enzymatic Pleurodesis for Malignant Pleural Effusions

    SBC: AERIS THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Aeris Therapeutics, Inc. of Woburn, MA. It will examine the feasibility of using a novel enzyme based-system to produce safe, clinically-effective pleurodesis for treatment of malignant pleural effusions. Preliminary data, summarized in this application, suggest that an enzymatic system has the potential for bei ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  6. Breath Analysis using Quantum Cascade Lasers

    SBC: AERODYNE RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): The analysis of components in human breath is a powerful non-invasive technique for the diagnosis and monitoring of asthma, cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). The presence of elevated levels of nitric oxide (NO), carbon monoxide (CO), and ethane (C2H6) in the breath have been identified as biomarkers of these diseases, wh ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Digital Fluoroscopy for Cardiac Imaging

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Real-time or dynamic radiographic imaging (fluoroscopy) provides vital information concerning internal organ structure, flow of contrast agents and in-vivo instrument positioning. Fluoroscopy is a very important modality for cardiac and vascular imaging including subtraction angiography where it is used for locating and evaluating cardiac structures, major v ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Direct Conversion Dental Sensor

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Radiation Monitoring Devices (RMD) proposes to develop a new dental x-ray imager that will have all the advantages of a digital technology and retain the most desirable aspects of image quality that film emulsions provide. The device will be a blend of two technologies - silicon based imaging arrays and semiconductor x-ray conversion layers. RMD will work on ta ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Digital 2-D Neutron Detector for Protein Function Sudies

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Information on the structure and function of proteins is important for unveiling the biological processes taking place on a molecular level. X-ray crystallography has been successful in determining protein structure, however is not well suited for analyzing hydrogen atoms and water molecules. It has been shown that the thermal neutrons are a far better tool for ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  10. High Sensitivity, 2-D Solid State Sensor Array/Rapid MCG

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Magnetocardiography (MCG) has been shown to offer powerful disease detection and diagnostic capabilities in both humans and animals not readily achieved with standard ECG and echocardiography, including the ability to map ischemic regions in the heart, and monitor arrhythmia. Fetal magnetocardiography (fMCG) has been successfully employed for the non-invasive s ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government